Robert Oliver, MD
Plastic and Reconstructive Surgery · Birmingham, ALNPI 1891880928
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), other and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Integra Lifesciences Corporation at 40.9% of the total. Reporting peaked in 2024 at $3,233 and has fallen 65.4% since, to $1,119 in 2025.
Across 85 payments — averaging $78.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- Musculoskeletal Transplant Foundation Inc.$1K
- AbbVie$707
- Sientra, Inc.$662
- Davol Inc.$525
- TELA Bio, Inc.$233
- plus $514 from 9 others
What the payments were for
- Consulting fees$501%
- Speaking & faculty fees$5258%
- Travel & lodging$1,15517%
- Food & beverage$3,48152%
- Other$1,42822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 13 | $2,716 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $1,283 |
| AbbVie(2 entities) | 28 | $707 |
| Sientra, Inc. | 12 | $662 |
| Davol Inc. | 1 | $525 |
| TELA Bio, Inc. | 10 | $233 |
| Avita Medical Americas, LLC | 1 | $156 |
| Pacira Pharmaceuticals Incorporated | 4 | $115 |
| Motiva USA, LLC | 4 | $80 |
| Medtronic | 1 | $50 |
| TEI Biosciences Inc | 2 | $43 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Johnson & Johnson | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Biocomposites Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,639 in reported general payments places this provider in the 85th percentile of 35 plastic and reconstructive surgery providers in Alabama.
See all plastic and reconstructive surgery providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 47 | $702 |
| Doxycycline Hyclate | 40 | $424 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 65 | $325 |
| Ondansetron Hcl | 36 | $116 |
| Ondansetron OdtOndansetron | 13 | $69 |
| Ibuprofen | 13 | $65 |
| Promethazine Hcl | 16 | $36 |
| Gabapentin | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Birmingham
- Brad DenneyBirmingham$21K
- Michael BeckensteinBirmingham$10K
- Paul SauerBirmingham$6K
- Jonathan AntonettiBirmingham$4K
- Richard FixBirmingham$2K
- Jorge de la TorreBirmingham$1K
- William RifkinBirmingham$1K
- Alexandre PrassinosBirmingham$885
- Luis VasconezBirmingham$160
- John GrantBirmingham$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.